Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 15,420
-760 (-4.70%)
Feb 13, 2025, 9:00 AM KST
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 175.84 billion as of February 21, 2025. Its market cap has increased by 68.16% in one year.
Market Cap
175.84B
Enterprise Value
170.89B
Revenue
2.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,420.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 175.84B, a decrease of -51.23%. That is a compound annual growth rate of -17.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 175.84B | -3.18% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.35T |
| Celltrion | 37.80T |
| Yuhan | 9,163.93B |
| SK Biopharmaceuticals | 9,013.86B |
| SK bioscience | 3,748.92B |
| Hanmi Pharm. | 3,404.64B |
| Peptron | 2,152.68B |
| Hanall Biopharma | 1,985.31B |